Euglycemic Diabetic Ketoacidosis With Prolonged Glucosuria Associated With the Sodium-Glucose Cotransporter-2 Canagliflozin

Journal of Investigative Medicine High Impact Case Reports- United Kingdom

doi 10.1177/2324709617712736

Full Text

Abstract

Available in

Date

Authors

Publisher

SAGE Publications

Related search

Sodium Glucose Cotransporter-2 (SGLT-2) Inhibitor Related Diabetic Ketoacidosis

European Scientific Journal ESJ
2019Spanish

Euglycemic Diabetic Ketoacidosis Induced by Empagliflozin, Sodium-Glucose Cotransporter-2 Inhibitor, in Patient With Diabetes Mellitus Type 2 After Thoracic Surgery

Lijecnicki Vjesnik
Medicine
2020English

Prolonged Glucosuria and Relapse of Diabetic Ketoacidosis Related to SGLT2‐inhibitor Therapy

Endocrinology, Diabetes & Metabolism
2020English

Increased Grip Strength With Sodium-Glucose Cotransporter 2

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2016English

Relationship Between Euglycemic Diabetic Ketoacidosis and SGLT-2 Inhibitors

Global Journal of Endocrinological Metabolism
2018English

Heart Failure Prevention With Sodium‐glucose Cotransporter 2 Inhibitors

Journal of Diabetes
EndocrinologyMetabolismDiabetes
2019English

Sodium–glucose Co-Transporter 2 Inhibitors: Think Twice About Diabetic Ketoacidosis

2018English

Sodium Glucose Cotransporter 2 Inhibitor Canagliflozin Attenuates Liver Cancer Cell Growth and Angiogenic Activity by Inhibiting Glucose Uptake

International Journal of Cancer
Cancer ResearchOncology
2017English

Euglycemic Diabetic Ketoacidosis Secondary to Dapagliflozin in a Patient With Colon Malignancy

Case Reports in Endocrinology
EndocrinologyMetabolismDiabetes
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy